Print

Print


UK study finds new alternative treatment for bone loss

BOSTON (February 18, 1998 5:24 p.m. EST http://www.nando.net) - An alternative
treatment for protecting older women from bone loss is almost as effective as
conventional hormone treatment, researchers report.

In tests on 1,609 post-menopausal women at risk for osteoporosis, or bone
loss, a team of scientists report in Thursday's New England Journal of
Medicine that the drug "alendronate increases bone mineral density at most
sites" in the body.

Alendronate is sold under the brand name Fosamax by Merck & Co. Inc., which
financed the study.

Osteoporosis is a natural part of aging, especially in post-menopausal women
whose bodies have stopped producing estrogen and progesterone. It is a major
health problem for the elderly because the weakened bones may break.

Doctors have known for years that giving synthetic forms of estrogen and
progesterone can slow bone loss.

Unfortunately, the treatment can cause bleeding and breast tenderness and may
also heighten the risk of breast cancer.

Alendronate, "therefore provides an alternative to estrogen" and progesterone
treatment, said the team headed by Dr. David Hosking of the University of
Nottingham in the United Kingdom.

In the study, treatments with estrogen and progestin (a synthetic form of
progesterone) were most effective at making bones stronger. But alendronate
worked nearly as well without the side effects.

The researchers also found that a daily dose of 5 milligrams of alendronate
was more effective than a 2.5 milligram dose.

"The proportion of women who lost more than 2 percent of total-body mineral
density was 42 percent in the placebo group, 19 percent in the group given the
2.5-mg dose of alendronate, and 9 percent in the group given the 5-mg dose,"
they said.

However, the drug did not work for everyone. The researchers cautioned that
some women getting the medicine still lost bone mass, while the estrogen-
progesterone combination had few failures.

Copyright 1998 Nando.net
Copyright 1998 Reuters News Service

janet paterson
50-9 / sinemet-selegiline-prozac
almonte-ontario-canada / [log in to unmask]